QoL after TTVR: 1-Year Results from TRISCEND II Pivotal Trial | JACC | TCT 2024

Author Suzanne Arnold, MD, and JACC Associate Editor Dennis T. Ko, MD, discuss the TRISCEND II trial, which evaluated the impact of transcatheter tricuspid valve replacement on quality of life in patients with severe tricuspid regurgitation. Dr. Suzanne Arnold highlights that the procedure significantly improved patients' quality of life, particularly at six months, with greater benefits observed in those with more severe regurgitation at baseline. However, the study did not show a significant reduction in heart failure hospitalizations, possibly due to low event rates and differences in the nature of tricuspid regurgitation.
Related content: www.jacc.org/d...
#jaccjournals #jacc #tct2024